Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 04, 2016 16:05 ET | Source: StemCells, Inc.

Ian Massey, President and CEO of StemCells, Inc., to Participate on a Regenerative Medicine Panel at Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference

NEWARK, Calif., Feb. 04, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Ian Massey, President and CEO of StemCells, Inc., will participate on a regenerative medicine...
January 28, 2016 11:15 ET | Source: StemCells, Inc.

CORRECTING and REPLACING -- StemCells, Inc. to Participate at the 2016 BIO CEO Conference and Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference

NEWARK, Calif., Jan. 28, 2016 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by StemCells, Inc. (Nasdaq:STEM), please note that in the third paragraph of the release,...
January 28, 2016 08:05 ET | Source: StemCells, Inc.

StemCells, Inc. to Participate at the 2016 BIO CEO Conference and Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference

NEWARK, Calif., Jan. 28, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will make presentations on the Company's programs, pipeline and operations at two...
January 11, 2016 08:05 ET | Source: StemCells, Inc.

StemCells, Inc. CEO Martin McGlynn Passes Baton to President and COO Ian Massey

NEWARK, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of central nervous system...
January 06, 2016 08:05 ET | Source: StemCells, Inc.

StemCells, Inc. to Participate at the 8th Annual Biotech Showcase Investor Conference

NEWARK, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will make a presentation on the Company's programs, pipeline and operations at the 8th...
December 23, 2015 08:05 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Strategic Realignment

NEWARK, Calif., Dec. 23, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of disorders of the...
November 18, 2015 16:05 ET | Source: StemCells, Inc.

StemCells, Inc. Interim Trial Data Show Motor Improvement in Patients With Cervical Spinal Cord Injury

NEWARK, Calif., Nov. 18, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of disorders of the...
November 12, 2015 08:05 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Webcast to Discuss Interim Results From the First Cohort in Its Phase II Study in Cervical Spinal Cord Injury

NEWARK, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of disorders of the...
November 02, 2015 16:05 ET | Source: StemCells, Inc.

StemCells, Inc. Reports Third Quarter 2015 Financial Results

Company to Host Call to Provide Interim Results from the First Cohort in its Phase II Pathway™ Study in Cervical Spinal Cord Injury NEWARK, Calif., Nov. 02, 2015 (GLOBE NEWSWIRE) --...
August 26, 2015 08:05 ET | Source: StemCells, Inc.

StemCells, Inc. to Participate at the Rodman & Renshaw 17th Annual Global Investment Conference

NEWARK, Calif., Aug. 26, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will make a presentation on the Company's programs, pipeline and operations at the...